DnB Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,917
| Closed | -$100K | – | 764 |
|
|
2025
Q1 | $100K | Sell |
18,917
-66,448
| -78% | -$352K | ﹤0.01% | 721 |
|
|
2024
Q4 | $577K | Buy |
+85,365
| New | +$577K | ﹤0.01% | 653 |
|
|
2024
Q3 | – | Sell |
-33,119
| Closed | -$248K | – | 726 |
|
|
2024
Q2 | $248K | Buy |
+33,119
| New | +$248K | ﹤0.01% | 682 |
|
|
2022
Q4 | – | Sell |
-26,086
| Closed | -$277K | – | 651 |
|
|
2022
Q3 | $277K | Buy |
+26,086
| New | +$277K | ﹤0.01% | 638 |
|